Endocanna Health

Endocanna Health, an industry leader in endocannabinoid system genomic testing, has been granted a first-of-its-kind U.S. patent for its DNA test, enabling hyper-personalized cannabinoid therapies based on user genetics. The patent, "Graphical User Interfaces for Determining Personalized...

Endocanna Health, has entered into an agreement with We Decode to conduct DNA testing and biomarker mapping for personalized phytocannabinoid suggestions, dosing based on metabolic function as well as drug-to-drug interactions focusing on supporting the veteran community. We Decode empowers...

Cannabis company Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) reported Wednesday that a company in which it holds a 30% non-controlling interest – Endocanna Health -  has entered into a strategic partnership with OMNI Medical Services. OMNI is a multi-state operator of...

Cannabinoid hyperemesis syndrome (CHS) is a rare condition that is believed to lead to intractable nausea, vomiting and abdominal pain in cannabis consumers. The condition can last days or weeks, returning for months. CHS's origins remain uncertain. Awareness of the condition has grown in...

A spectre is haunting the cannabis industry: strain names. Blue Dream, Sour Diesel, Girl Scout Cookies — these names came up as informal ways of identifying types of cannabis in the black market era, when growers and producers had little access to scientific-grade lab testing. Today...

"Genetics" is a word that is often tossed around in the cannabis industry. Even before the boom in legal cannabis, plant enthusiasts knew the value that gene science could add to the recreational and medical experience. For the most part, efforts in genetic research surrounding...

Versión en Español en El Planteo: Más Allá de Índica o Sativa: la Plataforma de Leafly para Identificar Cepas de Cannabis Cannabis information resource Leafly announced Tuesday the launch of a new brand for its website and mobile app. At the same time, the...

This week, we saw two pieces of news related to cannabinoid R&D. Medical Marijuana Inc Medical Marijuana, Inc. (OTC: MJNA) subsidiary Kannaway has entered a strategic partnership with Endocanna Health, a research and development biotechnology company specializing in endocannabinoid DNA testing...